The executive leadership team of Karyopharm Therapeutics is spearheaded by Richard Paulson, who serves as the President and Chief Executive Officer. Bringing extensive global biopharmaceutical experience across prominent pharmaceutical organizations and oncology business units, he guides the company's strategic roadmap, commercial growth initiatives for its flagship therapies, and disciplined operational expense management while advancing its clinical development pipeline forward.